Combined use of 123I-labelled BCD-F9 and 4C4 monoclonal antibody with dissimilar specificity for breast cancer: implication for the detection limit of immunolymphoscintigraphy in the assessment of axillary lymph node metastases (Q72169254)
Jump to navigation
Jump to search
scientific article published on 01 June 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined use of 123I-labelled BCD-F9 and 4C4 monoclonal antibody with dissimilar specificity for breast cancer: implication for the detection limit of immunolymphoscintigraphy in the assessment of axillary lymph node metastases |
scientific article published on 01 June 1994 |
Statements
Combined use of 123I-labelled BCD-F9 and 4C4 monoclonal antibody with dissimilar specificity for breast cancer: implication for the detection limit of immunolymphoscintigraphy in the assessment of axillary lymph node metastases (English)
C Schatten
M Barrada
R Mandeville
H Enzelsberger
P Angelberger
K Czerwenka
E Kubista